750586-06-2

Usage

Uses

Used in Pharmaceutical Industry:
Benzoic acid, 3-amino-6-bromo-2-methyl-, methyl ester is used as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and medications.
Used in Agrochemical Industry:
Benzoic acid, 3-aMino-6-broMo-2-Methyl-, Methyl ester is utilized as an intermediate in the production of herbicides and insecticides, helping to create effective solutions for pest and weed control in agriculture.
Used as a Preservative in Food and Beverage Industry:
Due to its antimicrobial properties, Benzoic acid, 3-amino-6-bromo-2-methyl-, methyl ester is used as a preservative in food and beverages, ensuring freshness and extending shelf life.
Used in Dye and Perfume Production:
Benzoic acid, 3-amino-6-bromo-2-methyl-, methyl ester is also employed in the production of dyes and perfumes, adding to the color and fragrance of various products.
Overall, Benzoic acid, 3-amino-6-bromo-2-methyl-, methyl ester is a multifaceted compound with applications in a wide range of industries, from pharmaceuticals and agrochemicals to food and beverage preservation and the production of dyes and perfumes.

Upstream product

• 18583-89-6 methyl 3-amino-2-methylbenzoate 

Downstream Products

• 1037840-79-1 methyl 5-bromo-1H-indazole-4-carboxylate 
• 1037841-33-0 methyl 3-amino-6-bromo-5-chloro-2-methylbenzoate 
• 269394-29-8 3,6-dibromo-2-methylbenzaldehyde 

Relevant academic research and scientific papers

Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist

To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5-6-5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5,4-d][1,3]oxazole, cyclopenta[c]pyrazolo[1,5-a]pyridine, i

2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS

The present invention relates to Nav1.8 Inhibitor 2,3-dihydroquinazolin compounds of Formula (X); wherein Y', X', B', R1', R2', R3', R5', R6', R7', and z1 are as defined herein; or pharmaceutically acceptable salts or tautomer forms thereof, corresponding pharmaceutical compositions or formulations, methods or processes of compound preparation, methods, compounds for use in, uses for and/or combination therapies for treating pain and/or pain-related or associated disease(s), disorder(s) or condition(s), respectively.

HETEROCYCLIC COMPOUND

Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, periphera

BICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s); R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s); Xa and Xb are each C, N, O or S; Xc and Xd are each C or N; m is 0-2; n is 1-3; ring A is a 5-membered ring optionally having substituent(s); ring B is a 6-membered ring optionally having substituent(s); and ring C is a 3- to 5-membered ring optionally having substituent(s), provided that when Xa, Xc and Xd are each C, then Xb is N or S, or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group opt